COPD as a Systemic Disease

被引:201
作者
Agusti, Alvar [1 ,2 ]
Soriano, Joan B. [2 ]
机构
[1] Hosp Univ Son Dureta, Serv Pneumol, Palma de Mallorca, Spain
[2] Fdn Caubet CIMERA Illes Balears, Mallorca, Spain
关键词
Comorbidities; COPD; Inflammation; Local; Systemic;
D O I
10.1080/15412550801941349
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Chronic obstructive pulmonary disease (COPD) represents an important and increasing burden throughout the world. Classically, COPD has been considered a respiratory condition only, mainly caused by tobacco smoking. However, COPD has important manifestations beyond the lungs, the so-called systemic effects. These include unintentional weight loss, skeletal muscle dysfunction, an increased risk of cardiovascular disease, osteoporosis, and depression, among others. Low-grade, chronic systemic inflammation is one of the key mechanisms underlying these systemic effects. Because these extra-pulmonary manifestations of COPD are common and/or may have significant implications for the patient wellbeing and prognosis, they warrant systematic screening and appropriate management in order to provide optimal medical care.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 57 条
[1]   NF-κB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight [J].
Agustí, A ;
Morlá, M ;
Sauleda, J ;
Saus, C ;
Busquets, X .
THORAX, 2004, 59 (06) :483-487
[2]   Hypothesis: Does COPD have an autoimmune component? [J].
Agusti, A ;
MacNee, W ;
Donaldson, M ;
Cosio, M .
THORAX, 2003, 58 (10) :832-834
[3]   Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease [J].
Agustí, AGN ;
Sauleda, J ;
Miralles, C ;
Gomez, C ;
Togores, B ;
Sala, E ;
Batle, S ;
Busquets, X .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (04) :485-+
[4]  
Agusti Alvar, 2007, Proc Am Thorac Soc, V4, P522, DOI 10.1513/pats.200701-004FM
[5]  
Agusti Alvar, 2006, Proc Am Thorac Soc, V3, P478, DOI 10.1513/pats.200603-058MS
[6]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[7]   Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers - A descriptive study [J].
Birring, SS ;
Brightling, CE ;
Bradding, P ;
Entwisle, JJ ;
Vara, DD ;
Grigg, J ;
Wardlaw, AJ ;
Pavord, ID .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (08) :1078-1083
[8]   COPD and osteoporosis [J].
Biskobing, DM .
CHEST, 2002, 121 (02) :609-620
[9]   Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases - Implications for pay for performance [J].
Boyd, CM ;
Darer, J ;
Boult, C ;
Fried, LP ;
Boult, L ;
Wu, AW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (06) :716-724
[10]  
Buist S, 2006, GLOBAL STRATEGY DIAG